Stock Events

Stock Events

M1 Aesthetics 

€21.00
0
+€0.00+0%Tuesday 20:00

Statistics

Day High
-
Day Low
-
52W High
21
52W Low
21
Volume
-
Avg. Volume
0
Mkt Cap
109.81M
P/E Ratio
-
Dividend Yield
0.19%
Dividend
0.04

Upcoming

Dividends

0.19%Dividend Yield
Jul 2026
€0.04
Jul 2025
€0.04
Jul 2024
€0.04
Jul 2023
€1.20
Jul 2022
€1.10
10Y Growth
-18.25%
5Y Growth
-47.47%
3Y Growth
-67.82%
1Y Growth
N/A

Financials

2.75%Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
281.51MRevenue
7.74MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap268B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Haemato in the development and marketing of medical products.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a multinational pharmaceutical corporation that competes with Haemato in the pharmaceuticals market, particularly in the areas of research, development, and distribution of drugs.
Merck
MRK
Mkt Cap356.01B
Merck & Co., Inc. is a leading global biopharmaceutical company that competes with Haemato in the discovery, development, and commercialization of medicines and vaccines.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson is a comprehensive healthcare company that has a strong presence in the pharmaceuticals sector, making it a competitor to Haemato in various therapeutic areas.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline is a global healthcare company that engages in the creation and distribution of pharmaceuticals, vaccines, and consumer healthcare products, competing with Haemato.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie is a biopharmaceutical company that develops and markets therapies, directly competing with Haemato in the pharmaceuticals and healthcare market.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines, competing with Haemato in several therapeutic areas.
Sanofi
SNY
Mkt Cap95.65B
Sanofi is a global life sciences company that offers a wide range of pharmaceutical products, directly competing with Haemato in the healthcare and pharmaceutical sectors.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a pioneer in healthcare, focusing on pharmaceuticals and diagnostics, and competes with Haemato in the development and marketing of medical solutions.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Haemato in the discovery and development of prescription medicines.

About

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its own generic medicinal products. It provides pharmaceuticals in the areas of oncology, HIV/AIDS, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic treatments. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, medical laboratories, and hospitals. The company was founded in 1993 and is headquartered in Schönefeld, Germany.
Show More
CEO
Employees
147
Country
United Kingdom
ISIN
DE000A289VV1
WKN
000A289VV

Listings

MU
DE
HAE.MU
STU
DE
HAEK.STU
LSE
GB
0VZ7.LSE

0 Comments

Share your thoughts

FAQs

What is M1 Aesthetics stock price today?▼
The current price of HAEK.STU is €21.00 EUR — it has increased by +0% in the past 24 hours. Watch M1 Aesthetics stock price performance more closely on the chart.
What is M1 Aesthetics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange M1 Aesthetics stocks are traded under the ticker HAEK.STU.
Is M1 Aesthetics stock price growing?▼
HAEK.STU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year M1 Aesthetics has showed a +0% increase.
What is M1 Aesthetics market cap?▼
Today M1 Aesthetics has the market capitalization of 109.81M
What is M1 Aesthetics revenue for the last year?▼
M1 Aesthetics revenue for the last year amounts to 281.51M EUR.
What is M1 Aesthetics net income for the last year?▼
HAEK.STU net income for the last year is 7.74M EUR.
Does M1 Aesthetics pay dividends?▼
Yes, HAEK.STU dividends are paid annual. The last dividend per share was 0.04 . As of today, Dividend Yield (FWD)% is 0.19%.
How many employees does M1 Aesthetics have?▼
As of October 8, 2026, the company has 147 employees.
In which sector is M1 Aesthetics located?▼
M1 Aesthetics operates in the Energy sector.
When did M1 Aesthetics complete a stock split?▼
M1 Aesthetics has not had any recent stock splits.